|
|
General Research Protocol for Studies of Complex Atmospheres The Center's current research strategy is to create a new detailed database on pollutant mixture composition vs. health responses to serve as a platform for statistical analyses determining the species and combinations of air contaminants most closely associated with the different types of health responses associated with air pollution in population studies. To create the database, a consistent set of atmospheric analyses and health assays will be used to determine the dose-response relationships of the effects of several complex atmospheres having different, but overlapping, compositions. Both the composition of the inhaled atmospheres and the health responses will be measured more comprehensively than in previous laboratory or population studies. This new database will allow relationships between composition and health responses to be examined across a continuum of concentrations and combinations of pollutants in a manner that existing data sets do not allow. The use of "real world" atmospheres will also provide direct comparisons of the health effects of emissions from several sources whose health impacts are currently debated. The program's general research matrix is outlined in the following table.
Irritation Allergies Defenses Heart Cancer
Diesel exhaust +
+
+
+
+
Gasoline exhaust +
+
+
+
+
Road dust +
+
+
+
+
Wood smoke +
+
+
+
+
Tobacco smoke
+
+
+
+
+
Cooking fumes +
+
+
+
+
Coal combustion emissions
+
+
+
+
+
The general research protocol described below will be used to study each of the several complex atmospheres employed to develop the NERC database on exposure composition vs. health responses. The atmospheres were recommended and the general research protocol was approved by the Center's External Scientific Advisory Committee (ESAC). The order in which the atmospheres are studied, and the details of the generation methods and exposure concentrations, will be determined in consultation with the ESAC and the many government and non-government organizations supporting the Center on a case-by-case basis as the studies proceed. The following methods constitute the "core" protocol to be applied identically to all atmospheres. Complementary research involving more exploratory assays will be done on an opportunistic basis by collaborative arrangements, which are strongly encouraged by the Center.
I. Analyses of the Exposure Atmospheres First, The composition of the exposure atmospheres will be characterized in sufficient detail to allow for analyses of the relationship between health effects and specific inhaled compounds and classes of air contaminants. Identical analyses will be used for all atmospheres, even though the full range of chemical species will not be present in all. This approach parallels the use of identical health assays for all atmospheres, regardless of predicted outcome.
Particle analyses will include mass and number concentrations, size distributions, morphology, size-specific chemistry, and the mass fraction of adsorbed compounds. Gases and volatile hydrocarbons will be measured. Particle-bound and semi-volatile organic compounds will be speciated in detail by chemical class and individual compounds. Inorganic ions and elements will also be measured. The bacterial mutagenicity of the particle-bound and semi-volatile organic fractions will be measured. The analyses will include over 400 individual chemical compounds encompassing several physical and chemical classes, such as the following:
II. Exposures
Animals will be exposed to the atmospheres by inhalation in whole-body chambers for 6 hours/day, 7 days/week. The length of exposure varies among the health assays up to a maximum of 6 months. The study of each atmosphere will include five exposure groups, one exposed to each of four concentrations (dilutions) of the test atmosphere and one clean air negative control group. Because the exposure-response characteristics of the health effects are of interest, it is desirable to produce measurable effects at a minimum of two exposure levels. However, it is also desirable to avoid extreme exposures that bear no relationship to plausible human exposures. Although not required, it is not a problem if the lowest exposure concentration proves to be a "no observed adverse effects" level. Because the compositions of the atmospheres differ, the exposure concentrations and the constituent used to set concentrations (e.g., particle concentration) may differ among the atmospheres. In general, the highest exposure concentration will mimic high-level, but still plausible, human exposures, and the lowest concentration will fall within the range of non-occupational exposures. In practice, the lower bound of exposure may be determined by the ability to control and measure low concentrations.
III. Health Assays A suite of standardized health assays will be applied identically to all atmospheres. The assays were selected on the basis of recommendations from a 1999 workshop. The criteria for selection included: 1) coverage of respiratory health outcomes suggested by population studies; 2) accepted interpretive value; 3) accepted use for hazard assessment; and 4) availability of established methods.
The assays were selected to span the overlapping adverse effects of irritant/inflammatory responses, amplification of allergies and asthma, impairment of respiratory defenses, alteration of heart and lung function, and cancer. Additional, more exploratory assays (e.g., gene micro-array) are also being used, but are not considered core assays to which we are committed to apply identically in studies of all atmospheres. Biological samples are being archived to allow additional evaluations as investigative techniques and collaborations develop in the future.
A. General Toxicity A set of toxicity assays typical of studies conducted for regulatory purposes will be applied to F344 rats, the standard bioassay species and strain. This will provide a foundation of basic information on the responses of the respiratory tract and other organs. Clinical observations and body weights will be recorded. Tissues from numerous organs will be collected, fixed, and archived for potential evaluation. Histopathological evaluations by light microspcopy will include the respiratory tract, heart, liver, kidney, and spleen. Lung lobes will be fixed at standard pressures to permit quantitative morphometry. Lung tissue will be frozen for the assays of carcinogenic potential described below, for gene micro-array analyses, and as archival samples for future use. In addition to standard hematological and serum chemistry assays, coagulation/clotting factors will also be measured. Bronchoalveolar lavage parameters will provide a screen for lung inflammation and cytotoxicity. Subjects: Male and female young adult F344/CrlBR Rats Protocol:
B. Carcinogenic Potential Cancer incidence is associated statistically with air pollution. Because it is impractical to conduct lifetime cancer bioassays of all the atmospheres, shorter-term responses known to be related to the potential for carcinogenesis will be used. These assays will not directly indicate human cancer risk, but will serve to characterize and compare the relative potential cancer hazards of the atmospheres and their components. Responses will be evaluated in both F344 rats and Strain A/J mice. Methylation of DNA is a common mechanism of chemical carcinogenesis; thus, both the total level of DNA methylation in lung tissue and methylation of selected cancer-related genes will be measured. Oxidative damage to DNA can be caused by inhaled materials; thus, the level of oxidative DNA adducts in lung tissue will be measured. The frequency of micronuclei in polychromatic erythrocytes from bone marrow will be determined as an assay for clastogenicity. As a short-term screen for tumorigenesis, the induction of lung adenomas in Strain A mice exposed for 6 months, then held without exposure for an additional 6 months will be determined. In addition to the animal assays, samples of particles and semi-volatile organic compounds taken from the exposure atmosphere will be assayed for mutagenic potential using the Ames bacterial reverse mutation assay. Subjects: Male and female young adult F344/CrlBR rats and Strain A/J mice Protocol:
C. Pulmonary Immune Responses and Airway Reactivity Air pollution is associated with exacerbation of asthma and allergic rhinitis. The potential role of pollutants in causing these conditions is uncertain. Some components found in air pollution have been shown to amplify allergic responses of animals and humans under high-dose laboratory conditions. Two issues regarding interactions between pollution and respiratory allergic responses will be addressed in the NERC studies. In one assay, the potential for concurrent exposure to affect the development of an airway immune response will be examined by sensitizing mice to antigen during exposure, followed by both specific (antigen) and nonspecific (bronchoconstrictor) challenge and measurement of airway constrictive responses, antibody production, and inflammatory responses. In another assay, the potential for exposure to increase responses in mice having pre-existing immune responses will be examined by establishing an allergic airway response before pollutant exposure, then measuring the response again after a few days of exposure to the atmospheres. BALB/c mice will be used because the primary concern for asthma arises from morbidity in children, and young mice of this strain are the only model for which the specific assays to be used have been adequately demonstrated. Subjects: Male BALB/c mice exposed to ovalbumin (OVA) antigen Protocol:
D. Resistance to Respiratory Infection The occurrence of pulmonary infections, particularly bacterial pneumonia in the elderly and viral infections in infants, is associated statistically with air pollution. Air contaminants are thought to affect the host defense mechanisms important in resistance to infectious agents. Rather than studying each defense mechanism separately, we will examine the effect of exposure to the pollutant atmospheres on the integrated defenses of the respiratory tract by challenging C57/B6 mice with Pseudomonas aeruginosa bacteria. The colonization of the lung (amount of viable agent remaining at a given time) will be the key outcome parameter. The C57/B6 mouse is the best-characterized model for this assay. Subjects: Young adult male C57/B6 mice challenged with Pseudomonas aeruginosa Protocol: After 1 week or 6 months of exposure:
E. Cardiac Effects Epidemiological data indicate an association between short-term increases in airborne pollutants, cardiovascular mortality and morbidity, and subclinical changes in the electrocardiogram (ECG). These changes have primarily been observed in elderly subjects with pre-existing cardiac disease. Laboratory studies using high concentrations of various air contaminants have produced ECG changes in old rats, rats treated to induce pulmonary hypertension, normal dogs, and dogs with experimentally induced coronary occlusion. Changes have been noted both during exposure and during days following exposure. The numbers of animals required to evaluate cardiac effects with robust statistics and the numbers of exposure groups preclude the use of dogs for the NERC studies. We will examine the impact of a 1-week exposure on the cardiac function of mid-aged rats having genetic hypertension. This strain of rats has been shown to have increased sensitivity to inhaled ambient particles. Subjects: Male and female SHR/crib (spontaneously hypertensive) rats Protocol:
For more information, view the Center’s web site at www.nercenter.org, or contact: Lovelace Respiratory Research Institute Albuquerque, NM 87108 USA Phone: 505-348-9451 Fax: 505-348-4980 E-mail: mreed@lrri.org Or:
Joe L. Mauderly, DVM, NERC Director
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||